Avextra Unveils its Alliance for Evidence and Announces its Support of BELCANTO: A Clinical Trial for Oncology Patients
October 18, 2023 07:00 ET
|
Avextra AG
Avextra is launching its Alliance for Evidence-based Cannabis Medicine: a platform focused on collaborating with healthcare professionals and researchers to generate real-world patient data with the...
Avextra Continues its European Expansion, Successfully Exporting Medical Cannabis Extracts to Italy
May 17, 2023 07:00 ET
|
Avextra AG
Avextra has successfully exported EU-GMP standardised cannabis extracts manufactured at its German facility to its distribution partner in ItalyAvextra extracts are the first Made in Germany products...
C15 Solutions Anticipates Substantial Growth in European Cannabis Market Through Innovative Tech Platform
April 20, 2023 07:00 ET
|
C15 Solutions
Oakville, Ontario, April 20, 2023 (GLOBE NEWSWIRE) -- C15 Solutions (“C15” or the “Company”), a technology vendor delivering a customized eQMS (‘electronic Quality Management System’) for the...
Avextra AG Announces Closing of EU 17 Million Capital Raise
March 15, 2023 08:00 ET
|
Avextra AG
Avextra announces the closing of its EU 17 Million Convertible Loan Note (“CLN”) bridge capital raise. The CLN will automatically swap into equity at the next capital round currently in preparation. ...
Avextra Successfully Exports Oil-Based Cannabis Medicines to the United Kingdom
February 08, 2023 09:00 ET
|
Avextra AG
Avextra successfully exported EU-GMP standardised cannabis extracts manufactured in its German facility to its distribution partner in the United Kingdom Export is a significant milestone that...
Tilray Medical Relaunches Cannabis Oral Solution Across Ireland
October 04, 2022 07:00 ET
|
Tilray Brands, Inc.
LEAMINGTON, Ontario and CANTANHEDE, Portugal, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring...
Brains Bioceutical Opens UK’s Largest EU GMP-Grade Licensed Cannabinoid Research and Commercial Production Facility
September 29, 2022 01:00 ET
|
Brains Bioceutical Corp
VANCOUVER, British Columbia and SANDWICH, United Kingdom, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp (“Brains” or the “Company”), is pleased to announce the opening of its recently...
Tilray Medical Receives Approval to Extend Market Authorization in Italy
September 22, 2022 07:00 ET
|
Tilray Brands, Inc.
LEAMINGTON, Ontario and CANTANHEDE, Portugal, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company...
Tilray Initiates Roundtable With German Regulators to Kick-Off Draft Legislation to Legalize Adult-Use Cannabis in Germany
September 06, 2022 09:00 ET
|
Tilray Brands, Inc.
BERLIN, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today announced...
Optimi Health Completes Expansion Of On-Site Analytical Laboratory
May 11, 2022 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 11, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that it has completed a...